fluoxymesterone has been researched along with thalidomide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Berrebi, A; Feldberg, E; Shvidel, L; Spivak, I | 1 |
1 review(s) available for fluoxymesterone and thalidomide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for fluoxymesterone and thalidomide
| Article | Year |
|---|---|
Mini-dose of thalidomide for treatment of primary myelofibrosis. Report of a case with complete reversal of bone marrow fibrosis and splenomegaly.
Topics: Aged, 80 and over; Angiogenesis Inhibitors; Blood Transfusion; Bone Marrow; Combined Modality Therapy; Drug Therapy, Combination; Fluoxymesterone; Folic Acid; Humans; Male; Prednisone; Primary Myelofibrosis; Remission Induction; Splenomegaly; Thalidomide; Vitamin B Complex | 2007 |